A cohort study of bacteremic pneumonia
Authors:
- Cristina Vazquez GuillametCGCristina Vazquez Guillamet
- Rodrigo VazquezRVRodrigo Vazquez
- Jonas NoeJNJonas Noe
- Scott T. MicekSMScott T. Micek
- Marin H. KollefMKMarin H. Kollef
Open Access
- 1 August 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 95 (35) , e4708
Abstract
Bacteremic pneumonia is usually associated with greater mortality. However, risk factors associated with hospital mortality in bacteremic pneumonia are inadequately described. The study was a retrospective cohort study, conducted in Barnes-Jewish Hospital (2008–2015). For purposes of this investigation, antibiotic susceptibility was determined according to ceftriaxone susceptibility, as ceftriaxone represents the antimicrobial agent most frequently recommended for hospitalized patients with community-acquired pneumonia as opposed to nosocomial pneumonia. Two multivariable analyses were planned: the first model included resistance to ceftriaxone as a variable, whereas the second model included the various antibiotic-resistant species (methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa, and Enterobacteriaceae). In all, 1031 consecutive patients with bacteremic pneumonia (mortality 37.1%) were included. The most common pathogens associated with infection were S aureus (34.1%; methicillin resistance 54.0%), Enterobacteriaceae (28.0%), P aeruginosa (10.6%), anaerobic bacteria (7.3%), and Streptococcus pneumoniae (5.6%). Compared with ceftriaxone-susceptible pathogens (46.8%), ceftriaxone-resistant pathogens (53.2%) were significantly more likely to receive inappropriate initial antibiotic treatment (IIAT) (27.9% vs 7.1%; P < 0.001) and to die during hospitalization (41.5% vs 32.0%; P = 0.001). The first logistic regression analysis identified IIAT with the greatest odds ratio (OR) for mortality (OR 2.2, 95% confidence interval [CI] 1.5–3.2, P < 0.001). Other independent predictors of mortality included age, mechanical ventilation, immune suppression, prior hospitalization, prior antibiotic administration, septic shock, comorbid conditions, and severity of illness. In the second multivariable analysis that included the antibiotic-resistant species, IIAT was still associated with excess mortality, and P aeruginosa infection was identified as an independent predictor of mortality (OR 1.6, 95% CI 1.1–2.2, P = 0.047), whereas infection with ceftriaxone-resistant Enterobacteriaceae (OR 0.6, 95% CI 0.4–1.0, P = 0.050) was associated with lower mortality. More than one-third of our patients hospitalized with bacteremic pneumonia died. IIAT was identified as the most important risk factor for hospital mortality and the only risk factor amenable to potential intervention. Specific antibiotic-resistant pathogen species were also associated with mortality.Keywords
This publication has 55 references indexed in Scilit:
- Individualizing Risk of Multidrug-Resistant Pathogens in Community-Onset PneumoniaPLOS ONE, 2015
- Is a Strategy Based on Routine Endotracheal Cultures the Best Way to Prescribe Antibiotics in Ventilator-Associated Pneumonia?Chest, 2013
- A risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumoniaBMC Infectious Diseases, 2013
- Validation of a Clinical Score for Assessing the Risk of Resistant Pathogens in Patients With Pneumonia Presenting to the Emergency DepartmentClinical Infectious Diseases, 2011
- Impact of healthcare-associated acquisition on community-onset Gram-negative bloodstream infection: a population-based studyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2011
- Identifying new risk factors for Pseudomonas aeruginosa pneumonia in intensive care units: experience of the French national surveillance, REA-RAISINJournal of Hospital Infection, 2011
- Carbapenem-Resistant Enterobacteriaceae: Epidemiology and PreventionClinical Infectious Diseases, 2011
- Five years of nosocomial Gram-negative bacteremia in a general intensive care unit: epidemiology, antimicrobial susceptibility patterns, and outcomesInternational Journal of Infectious Diseases, 2006
- All Wales surveillance of methicillin-resistant Staphylococcus aureus (MRSA): The first year's results.Journal of Hospital Infection, 1999
- Bacteremic Nosocomial PneumoniaAmerican Review of Respiratory Disease, 1984